Edition:
United Kingdom

Luminex Corp (LMNX.OQ)

LMNX.OQ on NASDAQ Stock Exchange Global Select Market

20.55USD
15 Dec 2017
Change (% chg)

$0.18 (+0.88%)
Prev Close
$20.37
Open
$20.36
Day's High
$20.58
Day's Low
$20.35
Volume
288,923
Avg. Vol
65,645
52-wk High
$22.41
52-wk Low
$17.68

Chart for

About

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease... (more)

Overall

Beta: 0.17
Market Cap(Mil.): $906.10
Shares Outstanding(Mil.): 44.07
Dividend: 0.06
Yield (%): 1.17

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Luminex Corporation receives FDA clearance for Aries Group A Strep Assay

* Luminex Corporation receives FDA clearance for Aries Group A Strep Assay Source text for Eikon: Further company coverage:

31 Oct 2017

BRIEF-Luminex Corp reports Q3 earnings per share $0.40

* Luminex Corporation reports third quarter 2017 financial results

30 Oct 2017

BRIEF-Zicom Group says settlement agreement has been reached​ on ‍lawsuit filed by Luminex Corporation against Curiox Biosystems

* Refers to ‍lawsuit filed by luminex corporation against curiox biosystems; advises settlement agreement has been reached​ Source text for Eikon: Further company coverage:

25 Oct 2017

BRIEF-Luminex Corp - Labcorp agrees to extend commitment to Luminex Cystic Fibrosis

Sept 12 Laboratory Corporation Of America Holdings

11 Sep 2017

BRIEF-Zicom Group updates on litigation against Curiox Biosystems Inc​

* ‍Luminex Corporation has filed an original complaint against Curiox Biosystems Inc​

05 Sep 2017

BRIEF-Luminex Corporation Q2 earnings per share $0.13

* Luminex Corporation reports second quarter 2017 financial results

07 Aug 2017

BRIEF-Luminex Corporation receives FDA clearance for ARIES C. difficile assay

* Luminex Corporation receives FDA clearance for ARIES C. difficile assay

24 Jul 2017

Competitors

Earnings vs. Estimates